Filing Details

Accession Number:
0001104659-24-097257
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-05 12:06:41
Reporting Period:
2024-09-03
Accepted Time:
2024-09-05 12:06:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1671502 Quoin Pharmaceuticals Ltd. QNRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1958621 P. Denise Carter C/O Quoin Pharmaceuticals Ltd.
42127 Pleasant Forest Court
Ashburn VA 20148
Chief Operating Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2024-09-03 1,822 $0.63 11,179 No 4 P Direct
Ordinary Shares Acquisiton 2024-09-03 4,100 $0.66 15,279 No 4 P Direct
Ordinary Shares Acquisiton 2024-09-04 8,825 $0.75 24,104 No 4 P Direct
Ordinary Shares Acquisiton 2024-09-04 22,988 $0.80 47,092 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary shares of the Issuer.
  2. Effective July 18, 2023, the ratio of ADSs evidencing ordinary shares changed from 1 ADS representing five thousand (5,000) ordinary shares to 1 ADS representing sixty thousand (60,000) ordinary shares, which resulted in a 1 for 12 reverse split of the issued and outstanding ADSs. Effective November 8, 2023, the Issuer completed a 1 for 60,000 reverse split of the ordinary shares which resulted in the ratio of ADSs evidencing ordinary shares to be changed from 1 ADS representing sixty thousand (60,000) ordinary shares to 1 ADS representing one (1) ordinary share. The amount of ordinary shares reported in this column includes ordinary shares previously included in the Reporting Person's Form 3, adjusted to reflect the number of ordinary shares resulting from the 1 for 60,000 reverse split effective November 8, 2023.